Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. euicit

EUICIT

EU Intersex Citizenship

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EUICIT project word cloud

Explore the words cloud of the EUICIT project. It provides you a very rough idea of what is the project "EUICIT" about.

marginalised    secondment    least    disorders    framed    agendas    national    framework    documentary    countries    tensions    male    takes    italy    divergent    organisation    social    born    anatomical    theory    citizenship    participant    person    context    action    levels    assembled    switzerland    activism    healthcare    versus    sexual    explore    recommendations    views    debates    varied    easily    interdisciplinary    human    understandings    international    observation    uses    refers    types    ideally    people    policy    exist    medical    intersex    interviews    investigation    triangulated    expertise    actors    engaged    dsd    suited    activists    combined    implications    pressing    sex    depathologise    drawing    conflicts    either    experiences    council    gonadal    2000    gender    uk    section    oriented    seek    participative    revise    relationship    perspectives    claims    activist    qualitative    classifiable    zwischengeschlecht    chosen    euicit    chromosomal    democratic    actively    highlights    rights    highlight    zw    team    depathologisation    female    population   

Project "EUICIT" data sheet

The following table provides information about the project.

Coordinator		 UNIVERSITY OF HUDDERSFIELD 

Organization address
address: QUEENSGATE
city: HUDDERSFIELD
postcode: HD1 3DH
website: www.hud.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website https://research.hud.ac.uk/institutes-centres/ccid/projects/current_projects/intersex-dsd_human_rights/
 Total cost 183˙454 €
 EC max contribution 183˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-09-01   to  2019-09-04

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF HUDDERSFIELD UK (HUDDERSFIELD) coordinator 183˙454.00

Map

 Project objective

The EUICIT action addresses the rights claims and agendas of intersex people and those with Disorders of Sexual Development (DSD), in response to recent Council of Europe recommendations to revise medical and policy approaches. The term 'Intersex' refers to people born with sex characteristics (chromosomal, gonadal and/or anatomical) not easily classifiable as either male or female; at least 1 person in 2000 is intersex/has DSD. Intersex/DSD people are a highly marginalised section of the EU population. Conflicts exist between those who seek to depathologise intersex and those who seek rights within the medical framework (DSD-oriented. There is a pressing need for research that highlights the experiences, understandings, and views of intersex/DSD people within a European context. In particular, an investigation of debates about intersex versus DSD perspectives is necessary, because of the divergent human rights and social policy implications of these two approaches. EUICIT is framed within interdisciplinary citizenship and participative democratic approaches, in order to highlight human rights issues, and to explore tensions between medical-oriented rights claims and those that seek depathologisation. It uses triangulated qualitative research methods: documentary and policy analysis across the EU, interviews with activists and healthcare/policy actors in Italy, the UK and Switzerland, and participant observation in a secondment organisation (Zwischengeschlecht- ZW). The case study countries were chosen to represent varied types of intersex/DSD activism and relationship to the EU. ZW, which is based in Switzerland, takes a combined medical/activist approach; it is actively engaged in policy work at national and international levels and is ideally suited to fieldwork on the topic. The project team has been assembled to help the applicant develop her existing expertise, drawing in expertise of gender theory, citizenship and human rights.

 Publications

year authors and title journal last update
List of publications.
2019 Markus Bauer, Daniela Truffer, Daniela Crocetti
Intersex human rights
published pages: 1-26, ISSN: 1364-2987, DOI: 10.1080/13642987.2019.1671354 		The International Journal of Human Rights 2020-01-29
2019 Surya Monro, Daniela Crocetti, Tray Yeadon-Lee
Intersex/variations of sex characteristics and DSD citizenship in the UK, Italy and Switzerland
published pages: 1-18, ISSN: 1362-1025, DOI: 10.1080/13621025.2019.1645813 		Citizenship Studies 2020-01-29

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EUICIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EUICIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

POLINGO (2018)

The Politics of Legitimacy: Non-partisan global governance and networked INGO power in the global governance of post-war states

Read More  

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More  

ROSETTA (2020)

Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer

Read More